AB055. SOH24AB_245. Value of pre-treatment circulating inflammatory response markers in predicting response to neoadjuvant treatment of breast cancer: a systematic review & meta-analysis

Background: Systemic inflammatory response markers have been found to have a prognostic role in several cancers, but their value in predicting response to neoadjuvant chemotherapy is uncertain. A systematic review and meta-analysis of the literature was carried out to investigate this.